Dr. Marco Ruggiero
Molecular Biologist and Diagnostic Radiology specialist
Marco Ruggiero was born in Firenze, Italy in 1956. He graduated from the School of Medicine, in 1980. He has a PhD in Molecular Biology and a specialization in Diagnostic Radiology. He served in the NATO Army as Medical Officer. In 1984-1986 he worked at the Laboratory of Cellular and Molecular Biology of Burroughs Wellcome Co, where he published a paper in PNAS sponsored by Nobel Laureate Sir John Vane.
He worked at the National Cancer Institute of the National Institutes of Health in Bethesda, MD, where he performed research on oncogenes and signal transduction. He returned to Italy as Professor of Molecular Biology at the University of Firenze until his retirement in 2014. He moved to Arizona in 2015.
Together with his wife Dr. Stefania Pacini, he is the inventor of the probiotic yogurt “Bravo”, and its derivatives. Marco Ruggiero has invented “Rerum”, a powerful, non-protein, Macrophage Activating Factor (MAF) as well as a number of other products.
In 2017, together with Dr. Dietrich Klinghardt, he developed a revolutionary procedure denominated the "Ruggiero-Klinghardt Protocol" (RK Protocol) that represents a paradigm change with profound implications for diagnosis and treatment of chronic conditions ranging from silent infections to neurodegenerative diseases, autism and cancer. The RK Protocol represents a quantum leap in medical diagnostics and therapeutics whose implications for human health are comparable to those following the discovery of X-Rays or DNA.
In the same year, he developed a method to enhance efficacy of DNA vaccines and envisaged the concepts of relativistic time dilation and biological quantum entanglement as they relate to cancer, autism and chronic conditions.
According to a paper of his published in 2017, "as we slow down the passing of time at the level of DNA, everything about medicine will be revolutionized. Cells will have time to repair damages to the genome and the epigenome, diseases will be cured from the inside before they manifest themselves, and humans will be entitled to live without aging" (J Neurol Stroke, 2017 7(7): 00263. DOI: 10.15406/jnsk.2017.07.00263).
In 2017, he published a paper entitled "A Novel Approach to Klotho Aimed at Delaying and Reversing Aging" where he described the role of the anti-aging gene Klotho as is relates to time dilation and quantum entanglement (BAOJ HIV 2017, 3: 02).